Nimedical   Report issue

For profit Phase 4
Founded: Petah TIkva Israel (1992)
Status: No NME R&D (1992)

Organization Overview

First Clinical Trial
2016
NCT03080441
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (1)

midodrine (proamatine) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hypotension (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 1